Ares Launch Vehicles Development Awakens Historic Test Stands at NASA's Marshall Space Flight Center

This paper chronicles the rebirth of two national rocket testing assets located at NASA's Marshall Space Flight Center: the Dynamic Test Stand (also known as the Ground Vibration Test Stand) and the Static Test Stand (also known as the Main Propulsion Test Stand). It will touch on the historical significance of these special facilities, while introducing the requirements driving modifications for testing a new generation space transportation system, which is set to come on line after the Space Shuttle is retired in 2010. In many ways, America's journey to explore the Moon begins at the Marshall Center, which is developing the Ares I crew launch vehicle and the Ares V cargo launch vehicle, along with managing the Lunar Precursor Robotic Program and leading the Lunar Lander descent stage work, among other Constellation Program assignments. An important component of this work is housed in Marshall's Engineering Directorate, which manages more than 40 facilities capable of a full spectrum of rocket and space transportation technology testing - from small components to full-up engine systems. The engineers and technicians who operate these test facilities have more than a thousand years of combined experience in this highly specialized field. Marshall has one of the few government test groups in the United States with responsibility for the overall performance of a test program from conception to completion. The Test Laboratory has facilities dating back to the early 1960s, when the test stands needed for the Apollo Program and other scientific endeavors were commissioned and built along the Marshall Center's southern boundary, with logistics access by air, railroad, and barge or boat on the Tennessee River. NASA and its industry partners are designing and developing a new human-rated system based on the requirements for safe, reliable, and cost-effective transportation solutions. Given below are summaries of the Dynamic Test Stand and the Static Test Stand capabilities, along with an introduction to the new missions that these sleeping giants will be fulfilling as NASA readies the Ares I for service in the 2015 timeframe, and plans the development work for fielding the Ares V late next decade (fig. 1). Validating modern computer design models and techniques requires the sorts of data that can only be generated by these one-of-a-kind facilities

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis

Autologous haematopoietic stem cell transplantation has been tried as one experimental strategy for the treatment of patients with aggressive multiple sclerosis refractory to other immunotherapies. The procedure is aimed at ablating and repopulating the immune repertoire by sequentially mobilizing and harvesting haematopoietic stem cells, administering an immunosuppressive conditioning regimen, and re-infusing the autologous haematopoietic cell product. ‘Non-myeloablative' conditioning regimens to achieve lymphocytic ablation without marrow suppression have been proposed to improve safety and tolerability. One trial with non-myeloablative autologous haematopoietic stem cell transplantation reported clinical improvement and inflammatory stabilization in treated patients with highly active multiple sclerosis. The aim of the present study was to understand the changes in the reconstituted immune repertoire bearing potential relevance to its mode of action. Peripheral blood was obtained from 12 patients with multiple sclerosis participating in the aforementioned trial and longitudinally followed for 2 years. We examined the phenotype and function of peripheral blood lymphocytes by cell surface or intracellular staining and multi-colour fluorescence activated cell sorting alone or in combination with proliferation assays. During immune reconstitution post-transplantation we observed significant though transient increases in the proportion of CD4+FoxP3+ T cells and CD56high natural killer cell subsets, which are cell subsets associated with immunoregulatory function. CD8+CD57+ cytotoxic T cells were persistently increased after therapy and were able to suppress CD4+ T cell proliferation with variable potency. In contrast, a CD161high proinflammatory CD8+ T cell subset was depleted at all time-points post-transplantation. Phenotypic characterization revealed that the CD161highCD8+ T cells were mucosal-associated invariant T cells, a novel cell population originating in the gut mucosa but expressing the central nervous system-homing receptor CCR6. Detection of mucosal-associated invariant T cells in post-mortem multiple sclerosis brain white matter active lesions confirmed their involvement in the disease pathology. Intracellular cytokine staining demonstrated interferon γ and interleukin 17 production and lack of interleukin 10 production, a pro-inflammatory profile. Mucosal-associated invariant T cell frequency did not change in patients treated with interferon β; and was more depleted after autologous haematopoietic stem cell transplantation than in patients who had received high-dose cyclophosphamide (n = 7) or alemtuzumab (n = 21) treatment alone, suggesting an additive or synergistic effect of the conditioning regime components. We propose that a favourably modified balance of regulatory and pro-inflammatory lymphocytes underlies the suppression of central nervous system inflammation in patients with multiple sclerosis following non-myeloablative autologous haematopoietic stem cell transplantation with a conditioning regimen consisting of cyclophosphamide and alemtuzuma

An international comparative study of blood pressure in populations of European vs. African descent

Background: The consistent finding of higher prevalence of hypertension in US blacks compared to whites has led to speculation that African-origin populations are particularly susceptible to this condition. Large surveys now provide new information on this issue. Methods: Using a standardized analysis strategy we examined prevalence estimates for 8 white and 3 black populations (N = 85,000 participants). Results: The range in hypertension prevalence was from 27 to 55% for whites and 14 to 44% for blacks. Conclusions: These data demonstrate that not only is there a wide variation in hypertension prevalence among both racial groups, the rates among blacks are not unusually high when viewed internationally. These data suggest that the impact of environmental factors among both populations may have been under-appreciated

Measuring emotional support in family networks: Adapting the Family Network Method for individuals with a mild intellectual disability.

Informal supportive networks of individuals with intellectual disability have become increasingly important. The aim of this paper is to describe how the Family Network Method - Intellectual Disability (FNM-ID) offers a way to gather the perspective of people with mild intellectual disability on their family support. The FNM is designed to explore how individuals define their family contexts, and more specifically how they perceive existing supportive relationships in these contexts. By carefully piloting ways of questioning people with mild intellectual disability, systematic adaptations were made to the original FNM. Data obtained by the FNM-ID can be analysed using social network analysis. Thereby, the FNM-ID provides rich, theoretically significant information on emotional support in the family networks of individuals with mild intellectual disability. The FNM-ID is a useful and successfully adapted tool for other researchers and professionals to systematically explore the family support experiences of individuals with mild intellectual disability